- Home
- LNZA vs HYFT Comparison
LNZA vs HYFT Comparison
Compare LNZA & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LNZA | HYFT |
|---|---|---|
| Founded | 2005 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.2M | 66.8M |
| IPO Year | 2021 | 2017 |
Fundamental Metrics
Financial Performance| Metric | LNZA | HYFT |
|---|---|---|
| Price | $6.19 | $1.30 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $14.00 | $5.00 |
| AVG Volume (30 Days) | 50.9K | ★ 111.0K |
| Earning Date | 05-18-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 17.00 | N/A |
| Revenue | ★ $55,845,000.00 | N/A |
| Revenue This Year | $55.80 | N/A |
| Revenue Next Year | N/A | $29.18 |
| P/E Ratio | $0.35 | ★ N/A |
| Revenue Growth | ★ 12.61 | N/A |
| 52 Week Low | $5.02 | $0.99 |
| 52 Week High | $44.00 | $3.00 |
Technical Indicators
Market Signals| Indicator | LNZA | HYFT |
|---|---|---|
| Relative Strength Index (RSI) | 45.33 | 43.66 |
| Support Level | $5.79 | $1.26 |
| Resistance Level | $6.63 | $1.31 |
| Average True Range (ATR) | 0.35 | 0.06 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 23.83 | 14.71 |
Price Performance
Historical ComparisonAbout LNZA LanzaTech Global Inc.
LanzaTech Global Inc is a provider of carbon management and conversion technologies, focused on transforming waste materials into high-value fuels, chemicals, and critical industrial inputs. Its mission is to drive energy resilience, industrial competitiveness, and supply chain security by leveraging scalable biotechnology solutions to maximize the value of domestic resources. The company operates in North America, Europe, the Middle East, Africa (EMEA), Asia, and Australia, with the majority of its revenue generated from North America.
About HYFT MindWalk Holdings Corp.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.